Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
Prior 2024 Guidance (May 9, 2024) | Revised 2024 Guidance (August 8, 2024) |
U.S. LINZESS Net Sales | Mid-single digits % decline2 |
Total Revenue | $405 - $425 million |
Adjusted EBITDA1 | >$120 million Excludes potential CNP-104 option exercise |
Posted In: IRWD